246 related articles for article (PubMed ID: 4929907)
1. [Immunological treatment of leukemias].
Szmigiel Z
Pol Tyg Lek; 1971 Mar; 26(13):482-4. PubMed ID: 4929907
[No Abstract] [Full Text] [Related]
2. Immunology and malignant disease.
Klein E; Cochran AJ
Haematologia (Budap); 1971; 5(3):179-203. PubMed ID: 4108507
[No Abstract] [Full Text] [Related]
3. [The current state of the search for tumor-specific transplantation antigens in human leukemias].
Zintl F; Plenert W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(1):1-20. PubMed ID: 4104078
[No Abstract] [Full Text] [Related]
4. Current aspects of tumor immunology. Preface and introduction.
Weiss DW
Isr J Med Sci; 1973 Mar; 9(3):205-16. PubMed ID: 4575649
[No Abstract] [Full Text] [Related]
5. Summary: immunology of acute leukemia and Burkitt's tumor.
Southam CM
Cancer Res; 1967 Dec; 27(12):2554-6. PubMed ID: 4866768
[No Abstract] [Full Text] [Related]
6. Transplantation antigens and viral carcinogenesis.
Haughton G; Nash DR
Prog Med Virol; 1969; 11():248-306. PubMed ID: 4906871
[No Abstract] [Full Text] [Related]
7. [Immunotherapy of neoplasms].
Trepel F
Med Klin; 1971 Feb; 66(7):222-9. PubMed ID: 4324109
[No Abstract] [Full Text] [Related]
8. An insight into cancer immunology and immunotherapy.
Thompson RB
Prog Clin Pathol; 1975; 6():159-76. PubMed ID: 1105670
[No Abstract] [Full Text] [Related]
9. [Problems of the immunotherapy of malignant neoplasma].
Trapeznikov NN; Iavorskiĭ VV
Klin Med (Mosk); 1975 May; 52(5):15-22. PubMed ID: 1094178
[No Abstract] [Full Text] [Related]
10. [Tumor immunology].
Milas L; Silobrcić V
Lijec Vjesn; 1970; 92(1):5-33. PubMed ID: 4932237
[No Abstract] [Full Text] [Related]
11. [Problems of tumor immunity and the possibility of immunotherapy in tumor].
Shimoyama M
Nihon Rinsho; 1971; 29(6):1515-29. PubMed ID: 4933610
[No Abstract] [Full Text] [Related]
12. [Immunological tolerance].
Muramatsu S
Tanpakushitsu Kakusan Koso; 1973 Mar; 18(3):199-209. PubMed ID: 4576029
[No Abstract] [Full Text] [Related]
13. The role of immunology in the treatment of leukemias and hematosarcomas.
Mathé G; Schwarzenberg L; Amiel JL; Schneider M; Cattan A; Schlumberger JR
Cancer Res; 1967 Dec; 27(12):2542-53. PubMed ID: 4170385
[No Abstract] [Full Text] [Related]
14. [Relationship between immunity and disease course in hemoblastoses].
Tilz GP
Wien Med Wochenschr; 1972 Nov; 122(43):646-9. PubMed ID: 4655806
[No Abstract] [Full Text] [Related]
15. Immunologic enhancement.
Snell GD
Surg Gynecol Obstet; 1970 Jun; 130(6):1109-19. PubMed ID: 4914604
[No Abstract] [Full Text] [Related]
16. Malignancy as a complication of immunosuppressive therapy.
Leibowitz S; Schwartz RS
Adv Intern Med; 1971; 17():95-123. PubMed ID: 4145004
[No Abstract] [Full Text] [Related]
17. The immunology of tumors.
Burk MW; Mckhann CF
Surg Annu; 1973; 5():1-29. PubMed ID: 4602210
[No Abstract] [Full Text] [Related]
18. Dynamics of immunologic enhancement.
Kaliss N
Transplant Proc; 1970 Mar; 2(1):59-67. PubMed ID: 4940355
[No Abstract] [Full Text] [Related]
19. Inhibition of specific immune responses by feeding protein antigens. II. Effects of prior passive and active immunization.
Hanson DG; Vaz NM; Rawlings LA; Lynch JM
J Immunol; 1979 Jun; 122(6):2261-6. PubMed ID: 448128
[No Abstract] [Full Text] [Related]
20. [Immunological aspects in experimental oncology].
Thiele HG
Munch Med Wochenschr; 1971 Mar; 113(10):333-8. PubMed ID: 4323333
[No Abstract] [Full Text] [Related]
[Next] [New Search]
